m6A-modified AC026356.1 plays oncogenic roles in HCC via interacting with IGF2BP1 and enhancing IL11 mRNA stability, which leads to the activation of IL11/STAT3 signaling. This evidence concerns the gene IL11 and hepatocellular carcinoma.